DeepIntent, healthcare advertising technology company built to improve patient health and business outcomes, now offers pharmaceutical advertisers the ability to measure the real-world effectiveness of their entire media plan with the industry's fastest omnichannel measurement solution based on clinical data.
As part of the evolution of DeepIntent Outcomes™, the platform now features new measurement capabilities that surpass those of existing third-party measurement solutions, making it a one-stop shop for healthcare marketers. These features include:
These features are now available to all pharma marketers and across all platforms and publishers, irrespective of whether they run campaigns on DeepIntent's healthcare demand side platform (DSP).
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.